ACI — Albertsons Companies, Inc.
Is ACI overbought or oversold? Here is the current MarketMoodz read.
Albertsons Companies, Inc. (ACI) currently reads Overbought on the MarketMoodz overbought/oversold meter, as of August 19, 2026. The Consumer Defensive name (Grocery Stores) last closed at $12.12. The rating moved from Neutral to Overbought on August 19, 2026.
- Public ratingOverbought (as of August 19, 2026)
- Last close$12.12
- Last changeMoved from Neutral to Overbought on August 19, 2026
- SectorConsumer Defensive
- IndustryGrocery Stores
See all overbought Consumer Defensive stocks →
AI analysis
Albertsons Companies, Inc. (ACI) combines a defensive grocery business and pharmacy presence with near-term margin tailwinds from tariff refunds and longer-term upside from automation and healthcare adjacencies. The company benefits from recurring consumer demand and opportunities to improve unit economics through operations investments. Key uncertainties include competitive pressure, input cost inflation, capital intensity of automation and potential regulatory shifts around product reformulation. Overall outlook depends on execution of cost programs, ability to convert tariff-related benefits into sustainable margin improvement, and maintaining stable same-store sales.
Key factors
- Tariff-refund tailwind for large, import-dependent retailers that can boost near-term gross margins
- Defensive consumer staples positioning with broad grocery footprint and recurring demand for food and pharmacy items
- Pharmacy and clinic adjacencies present diversification opportunities (Medicare Advantage / senior care distribution)
- Operational efficiency upside from accelerating supply-chain and in-store automation investments
- Valuation gap versus broader market peers supports upside if margins stabilize and comp trends hold
Risks
- Intense competition from Walmart, Kroger, Amazon and discounters that can pressure pricing and market share
- Persistent inflationary cost pressure on COGS and wages could compress margins if not fully passed to consumers
- Execution risk on automation and reformulation initiatives, including upfront capital and integration costs
- Regulatory changes around ingredient labeling or pharmacy/healthcare could increase compliance costs
- Leverage or balance sheet constraints that limit strategic flexibility in a slower sales environment
- Low visibility on social sentiment and near-term consumer demand shifts that can affect comps
Latest MarketMoodz coverage
See today's live rating, score and targets
Members see the live hourly rating for ACI — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.
MarketMoodz